Update on Facial Erythema in Rosacea.
Journal
Journal of drugs in dermatology : JDD
ISSN: 1545-9616
Titre abrégé: J Drugs Dermatol
Pays: United States
ID NLM: 101160020
Informations de publication
Date de publication:
01 Aug 2021
01 Aug 2021
Historique:
entrez:
16
8
2021
pubmed:
17
8
2021
medline:
11
11
2021
Statut:
ppublish
Résumé
Dermatologists are cognizant of the multiple clinical manifestations of rosacea, particularly persistent facial erythema, which has been deemed to be the most prevalent diagnostic feature and often poses a significant negative impact on quality of life. To address the need to recognize rosacea as a single disease with multiple potential phenotypes, a new classification system has been developed by 28 clinical and scientific experts worldwide.
Identifiants
pubmed: 34397189
pii: S1545961621P0861X
doi: 10.36849/JDD.6062
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM